Latest Zocor Stories

The Firm is currently investigating Zocor lawsuits on behalf of individuals who suffered serious Zocor side effects. New York, New York (PRWEB) April 13, 2013 Bernstein Liebhard LLP notes that a new study is raising additional concerns about possible Zocor side effects, specifically kidney damage. The study, which was published online on March 19 in the British Medical Journal, found that patients treated with higher doses of statins like Zocor were 34% more likely to be hospitalized...

As Medline Plus (a service of the U.S. National Library of Medicine) published on March 20th, 2013, a new study reveals that high potency statins (incl. Zocor) are linked to increased risk for acute kidney injury. In light of these news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Zocor side effects. San Diego, CA (PRWEB) March 29, 2013 AttorneyOne.com, a...

According to court documents, on June 1st, 2012, Danielle Woolens filed a lawsuit in the Louisiana Eastern District Court (case no. 2:2012cv01408) alleging that Zocor led to kidney failure for the plaintiff. Zocor, which is also known by the generic name “Simvastatin”, manufactured by Merck Pharmaceuticals, is used to reduce bad cholesterol (LDL) and increase good cholesterol (HDL). In June 2011, the FDA posed restrictions in the use of the highest approved dose of the...

EDISON, N.J., July 15, 2011 /PRNewswire/ -- Crestor and Zocor are widely-used prescription strength drugs designed to lower "bad cholesterol". Both drugs are classified as "statins", medicine which lowers blood cholesterol levels by inhibiting HMG-CoA reductase. This group of drugs has had a controversial history, starting with Baycol, a drug similar to Crestor and Zocor, touted as a "super statin" before its recall from the market. Despite numerous objections from medical researchers and...

Highest approved dose of cholesterol-lowering medication could cause harm to muscles SILVER SPRING, Md., March 19 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today warned patients and healthcare providers about the potential for increased risk of muscle injury from the cholesterol-lowering medication Zocor (simvastatin) 80 mg. Although muscle injury (called myopathy) is a known side effect with all statins, today's warning highlights the greater risk of developing...

A large study has found the cholesterol pill Crestor significantly lowered the chance of death and heart attack among people with low cholesterol and no substantial risk factors for heart disease.The study, published online by the New England Journal of Medicine, provides the most compelling evidence to date for using a new test to identify those who may need treatment, said Dr. Elizabeth Nabel, director of the National Heart, Lung and Blood Institute.  Experts reviewing current guidelines...

By Toni Clarke BOSTON (Reuters) - Cholesterol-reducing statin drugs such as Lipitor and Zocor could benefit patients with a certain type of heart disease even if they don't have high cholesterol, according to newly analyzed data from a previously reported trial. Researchers led by Dr. Jeffrey Goldberger, director of clinical cardiac electrophysiology at Northwestern University, analyzed data from a five-year, 458-patient study of patients with nonischemic dilated cardiomyopathy who...

By Bill Berkrot and Randell PiersonDALLAS -- High doses of Pfizer Inc.'s cholesterol-lowering drug Lipitor failed in a high-stakes trial to help heart attack patients significantly more than moderate doses of Merck & Co.'s rival Zocor, researchers said on Tuesday.The aim of the study presented at the American Heart Association scientific meeting was to determine whether intensive lowering of "bad" LDL cholesterol with atorvastatin (Lipitor) would reduce the risk of death and...

No clear evidence exists that some widely-prescribed cholesterol-lowering drugs can decrease the risk of melanoma, a deadly and malignant skin cancer, according to a new review of recent studies.Robert Dellavalle, M.D., of Denver Veterans Affairs Medical Center and colleagues found no significant difference in melanoma rates between people taking statin or fibrate medication for high cholesterol and those who did not take either class of drug. The reviewers looked at 16 high-quality studies...